Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis (Q72395436)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

W F Clark

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

A Parbtani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 May 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

644-647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus?

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

NIH conference. Lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

The bimodal mortality pattern of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Mortality in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Why do patients with lupus nephritis die?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Omega-3 fatty acids in health and disease and in growth and development

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Haemostatic function and platelet polyunsaturated fatty acids in Eskimos

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Fatty acid composition of the plasma lipids in Greenland Eskimos

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

The composition of food consumed by Greenland Eskimos.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

The inverse relation between fish consumption and 20-year mortality from coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Effects of dietary enrichment with eicosapentaenoic acid upon autoimmune nephritis in female NZBXNZW/F1 MICE

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Dietary fish oil reduces progression of established renal disease in (NZB x NZW)F1 mice and delays renal disease in BXSB and MRL/1 strains

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Effect of eicosapentaenoic acid rich menhaden oil and MaxEPA on the autoimmune disease of Mrl/l mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Fish oil in lupus nephritis: clinical findings and methodological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Dietary α-linolenic acid and immunocompetence in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Mammalian lignan production from various foods

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Effects of dietary alpha- and gamma-linolenic acid on lipid metabolism in young and adult rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Increased urinary excretion of platelet activating factor in mice with lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Release of platelet-activating factor in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Glucocorticoid protection against PAF-acether toxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

Abrogation of MRL/lpr lupus nephritis by dietary flaxseed

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970273-1

7 January 2021

10.1016/S0272-6386(12)70273-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8172205%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference